LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3
Author:
Funder
Department of Science and Technology, Ministry of Science and Technology, India
Publisher
Elsevier BV
Subject
General Medicine,Biochemistry
Reference49 articles.
1. Global cancer in women: burden and trends;Torre;Cancer Epidemiol. Biomark. Prev.,2017
2. A nomogram prediction for the survival of patients with triple negative breast cancer;Lin;Oncotarget,2018
3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc. Natl. Acad. Sci. U. S. A.,2001
4. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc. Natl. Acad. Sci. U. S. A.,2003
5. Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies;He;Crit. Rev. Oncol. Hematol.,2018
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Research Progress of Long Non-coding RNA-ZFAS1 in Malignant Tumors;Cell Biochemistry and Biophysics;2024-07-26
2. An update on the molecular mechanisms of ZFAS1 as a prognostic, diagnostic, or therapeutic biomarker in cancers;Discover Oncology;2024-06-10
3. lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression;Pathology - Research and Practice;2024-06
4. Clinical Significance of LncRNAs SOX2-OT and NEAT1 in Esophageal Squamous Cell Carcinoma;2024-04-04
5. LncRNAs expression profile in a family household cluster of COVID‐19 patients;Journal of Cellular and Molecular Medicine;2024-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3